Skip to main content
Scott Plotkin, MD, Neurology, Boston, MA, Massachusetts General Hospital

ScottRPlotkinMDPhD

Neurology Boston, MA

Neurooncology

Professor of Neurology, Massachusetts General Hospital

Dr. Plotkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Plotkin's full profile

Already have an account?

  • Office

    55 Fruit St Yaw 9
    Brain Tumor Center Neuro-Oncology
    Boston, MA 02114
    Phone+1 617-724-8770
    Fax+1 617-724-8769
  • Is this information wrong?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Neuro-Oncology, 2002 - 2003
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1999 - 2002
  • Tulane University
    Tulane UniversityInternship, Internal Medicine, 1998 - 1999
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1998

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2023 - 2025
  • MA State Medical License
    MA State Medical License 2002 - 2025
  • LA State Medical License
    LA State Medical License 2002 - 2002
  • American Board of Psychiatry and Neurology Neurology
  • United council of neurological subspecialtiesNeuro-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Increasing Access to Specialty Care for Rare Diseases: A Case Study Using a Foundation Sponsored Clinic Network for Patients with Neurofibromatosis 1, Neurofibromatosi...  
    Scott R Plotkin, Justin T Jordan, BioMed Central

Lectures

  • Preliminary report of a multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinica... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • University of Miami Miller School of Medicine Selected for National NF2 Tumor Clinical Trial
    University of Miami Miller School of Medicine Selected for National NF2 Tumor Clinical TrialJune 1st, 2022
  • Wayne Biopharma Firm Targeting Rare Genetic Disorders Raises $6M
    Wayne Biopharma Firm Targeting Rare Genetic Disorders Raises $6MMay 1st, 2020
  • Antiangiogenesis Treatment Improves Hearing in Some NF2 Patients
    Antiangiogenesis Treatment Improves Hearing in Some NF2 PatientsJuly 8th, 2009
  • Join now to see all

Grant Support

  • Fetal Alcohol Effects On Blood Brain Barrier TransportNational Institute On Alcohol Abuse And Alcoholism1995–1997
  • Fetal Alcohol Effects On Blood Brain Barrier TransportNational Institute On Alcohol Abuse And Alcoholism1994

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Co-Founder, NF2 Therapeutics
  • Co-Founder, NFlection Therapeutics